Abstract
Debate exists as to patient experience, and the importance, of the working alliance (WA) in videoconferencing psychotherapy (VCP). This study used a two-phase explanatory sequential design to investigate the WA as a change process in VCP. Phase I: sessional VCP outcome and WA data were analysed using multilevel modelling (n = 46). Phase II: participants (n = 12) from Phase I were recruited to semi-structured interviews, analysed using thematic framework analysis. Results demonstrate: (1) a significant correlation between WA and outcome (F(1, 15.19) = 25.01, p < 0.001), (2) previous session WA significantly predicted outcome in the next session (F(1, 355.61) = 4.47, p < 0.05), and (3) previous session outcome significantly predicted next session WA (F(1, 55.3) = 15.19, p < 0.001), with three core themes explaining patient experience (engaging with the medium, connection with the therapist, and working via the medium). Results are discussed and future research recommended.
Highlights
The interest in drug detection is increasing due to high demand in sporting competitions and police investigations
The results demonstrate that the sensor responds to the presence of carboxyl-fentanyl in serum with an increase in wavelength separation with increase of carboxyl-fentanyl concentration (Fig. S6a)
NanoMIPs imprinted with carboxyl-fentanyl were successfully syn thesised and collected via a solid-phase approach
Summary
The interest in drug detection is increasing due to high demand in sporting competitions and police investigations. In addition to the already known and scheduled substances, new psychoactive substances are continuously being brought to the market, rising serious worries as their pharmacological and toxicological effects are mostly unknown (A and European Drug Repo, 2017), in addition to the lack of routine testing in standard toxicology analysis (Oldenhof et al, 2020). Between 2012 and 2017, more than a dozen additional fentanyl analogues have entered the illicit opioid market. Some of these ana logues have been re-discovered by traffickers from research work carried out between the 1960s and 1990s. These substances were described in the scientific literature, but never developed into pharma ceutical products. Butyrfentanyl, fur anylfentanyl, and ocfentanil (Crime, 2017)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
